Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
ArchiMed Expands Clinical Research Organization Portfolio
ArchiMed announced it has acquired two clinical contract research organizations (CRO): Port Jefferson, New York-based Symbio, LLC and Proinnovera GmbH, in Munster, Germany. According to data captured in the LevinPro HC database, this transaction marks the 37th CRO acquisition of the year. Between January 1, 2022, and November 17, 2022, there were also 37 CRO transactions announced, showing a healthy and stable CRO market. Symbio offers expertise in proof-of-concept, medical devices and Phase 1 – Phase 4 clinical studies and has completed more than 200 clinical studies to date. Proinnovera was founded in 1997. It serves more than 100,000 patients across more than 4,500... Read More »
Bharath Home Medicare Acquires Indian Company Strata Meditech
Bharath Home Medicare announced on November 16 the successful acquisition of Strata Meditech, an India-based company offering occupational health management and annual medical checkups. Strata Meditech was founded in 2015 and serves more than 50 corporate clients. Bharath Home Medicare provides holistic home health care services to all age groups with electronic medical records. Their services include patient support, vaccinations, physiotherapy, speech therapy, diagnostics and medical equipment rental and sales. The transaction was completed on November 10, 2023. Strata’s operations will be overseen by Varadharajan K. as Director and Rajasekharan N.S. as Chief Business... Read More »
Ajinomoto Acquires Forge Biologics for $620 Million
Ajinomoto Co., Inc. and Forge Biologics announced on November 13 that they have entered into a definitive agreement by which Ajinomoto will acquire Forge Biologics in an all-cash deal for $620 million. Forge Biologics is a viral vector and plasmid contract development and manufacturing organization (CDMO) and clinical-stage therapeutics company, enabling access to potentially life-changing gene therapies by bringing them from concept to reality. All development and manufacturing is done at the Hearth, Forge Biologics’ 200,000 square-foot custom-designed cGMP facility in Columbus, Ohio, where the CDMO has more than 300 employees. Ajinomoto Co. is a global manufacturer of... Read More »
